First Time Loading...
S

Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607

Watchlist Manager
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Watchlist
Price: 17.92 CNY -0.78% Market Closed
Updated: May 4, 2024

Shanghai Pharmaceuticals Holding Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai Pharmaceuticals Holding Co Ltd
Operating Income Peer Comparison

Comparables:
1099
600998
C
600511
000963
C
000028

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
S
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Operating Income
¥8.9B
CAGR 3-Years
5%
CAGR 5-Years
9%
CAGR 10-Years
12%
Sinopharm Group Co Ltd
HKEX:1099
Operating Income
¥22.9B
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
16%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Operating Income
¥3.9B
CAGR 3-Years
-2%
CAGR 5-Years
11%
CAGR 10-Years
18%
C
China National Medicines Corp Ltd
SSE:600511
Operating Income
¥2.4B
CAGR 3-Years
16%
CAGR 5-Years
5%
CAGR 10-Years
21%
Huadong Medicine Co Ltd
SZSE:000963
Operating Income
¥3.7B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
15%
C
China National Accord Medicines Corp Ltd
SZSE:000028
Operating Income
¥2.4B
CAGR 3-Years
4%
CAGR 5-Years
10%
CAGR 10-Years
12%

See Also

What is Shanghai Pharmaceuticals Holding Co Ltd's Operating Income?
Operating Income
8.9B CNY

Based on the financial report for Dec 31, 2023, Shanghai Pharmaceuticals Holding Co Ltd's Operating Income amounts to 8.9B CNY.

What is Shanghai Pharmaceuticals Holding Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
12%

Over the last year, the Operating Income growth was 7%. The average annual Operating Income growth rates for Shanghai Pharmaceuticals Holding Co Ltd have been 5% over the past three years , 9% over the past five years , and 12% over the past ten years .